This activity will provide an interdisciplinary educational forum in which to update state-of-the-art science including novel therapies for inherited cancers, discuss real-world cases, curate interesting pedigrees and prepare case summaries to disseminate new knowledge in translational genomics and evidence-based clinical management of high-risk patients and their family members.
Click on the "Get Started!" tab to register!
This activity is brought to you in partnership with City of Hope.
At the conclusion of this activity, participants will be able to:
Identify how advanced concepts in genetics, genomics, and next generation sequencing (NGS) technologies;
Recognize advances in the clinical management of patients with inherited cancer syndromes including breast, prostate, gastrointestinal, and hematologic malignancies;
Discuss integration of novel cancer therapies based on genomic alterations in tumor tissue that may reveal germline mutations such as MLH1 and BRCA mutations into the practice of oncology;
Describe how to manage cancer patients from high risk families using a globally-informed perspective;
Discuss emerging models for cancer risk assessment and genetic testing including integration of a polygenic risk score;
Recognize the ethical, legal, and social implications of genomic testing in healthy populations.
This activity has been designed for physicians, physician assistants, advanced nurse practitioners, genetic counselors, oncology nurses, and other healthcare professionals currently involved in providing cancer genetics risk assessment services or initiating such services in their healthcare system. Special efforts will be made to educate clinicians practicing in geographically or socioeconomically underserved communities.
